RAS Proteins and Their Regulators in Human DiseaseDhirendra K. Simanshu(Leidos (United States)), Dwight V. Nissley(Leidos (United States)), Frank McCormick(Leidos (United States))CellJune 1, 201710.1016/j.cell.2017.06.009Cited by 1,918Open AccessFull TextSaveCiteExport RISWatch citationsAbstractRelated PapersThe structural basis of the activation of Ras by SosP. Ann Boriack‐Sjodin, S.M. Margarit, Dafna Bar‐Sagi et al.|Nature|1998|800Biochemical and Structural Analysis of Common Cancer-Associated KRAS MutationsJohn C. Hunter, Anuj Manandhar, Martin A. Carrasco et al.|Molecular Cancer Research|2015|777Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic miceNancy E. Kohl, Charles A. Omer, Michael W. Conner et al.|Nature Medicine|1995|540Discovery of Small Molecules that Bind to K‐Ras and Inhibit Sos‐Mediated ActivationQi Sun, Jason P. Burke, Jason Phan et al.|Angewandte Chemie International Edition|2012|499Post‐translational processing of p21ras is two‐step and involves carboxyl‐methylation and carboxy‐terminal proteolysis.L. Gutiérrez, Anthony I. Magee, Catriona Marshall et al.|The EMBO Journal|1989|465